1. Home
  2. PVLA vs PHLT Comparison

PVLA vs PHLT Comparison

Compare PVLA & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • PHLT
  • Stock Information
  • Founded
  • PVLA 2015
  • PHLT 1976
  • Country
  • PVLA United States
  • PHLT United States
  • Employees
  • PVLA N/A
  • PHLT N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • PHLT Other Consumer Services
  • Sector
  • PVLA Health Care
  • PHLT Consumer Discretionary
  • Exchange
  • PVLA Nasdaq
  • PHLT Nasdaq
  • Market Cap
  • PVLA 253.2M
  • PHLT 267.0M
  • IPO Year
  • PVLA N/A
  • PHLT N/A
  • Fundamental
  • Price
  • PVLA $22.30
  • PHLT $3.43
  • Analyst Decision
  • PVLA Strong Buy
  • PHLT
  • Analyst Count
  • PVLA 7
  • PHLT 0
  • Target Price
  • PVLA $46.29
  • PHLT N/A
  • AVG Volume (30 Days)
  • PVLA 81.8K
  • PHLT 177.1K
  • Earning Date
  • PVLA 08-15-2025
  • PHLT 08-06-2025
  • Dividend Yield
  • PVLA N/A
  • PHLT N/A
  • EPS Growth
  • PVLA N/A
  • PHLT N/A
  • EPS
  • PVLA N/A
  • PHLT N/A
  • Revenue
  • PVLA N/A
  • PHLT $128,916,000.00
  • Revenue This Year
  • PVLA N/A
  • PHLT $11.03
  • Revenue Next Year
  • PVLA N/A
  • PHLT $11.23
  • P/E Ratio
  • PVLA N/A
  • PHLT N/A
  • Revenue Growth
  • PVLA N/A
  • PHLT 11.76
  • 52 Week Low
  • PVLA $11.17
  • PHLT $2.17
  • 52 Week High
  • PVLA $29.27
  • PHLT $4.35
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • PHLT N/A
  • Support Level
  • PVLA N/A
  • PHLT N/A
  • Resistance Level
  • PVLA N/A
  • PHLT N/A
  • Average True Range (ATR)
  • PVLA 0.00
  • PHLT 0.00
  • MACD
  • PVLA 0.00
  • PHLT 0.00
  • Stochastic Oscillator
  • PVLA 0.00
  • PHLT 0.00

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About PHLT Performant Healthcare Inc. Common Stock

Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.

Share on Social Networks: